JP2023524061A5 - - Google Patents

Info

Publication number
JP2023524061A5
JP2023524061A5 JP2022566315A JP2022566315A JP2023524061A5 JP 2023524061 A5 JP2023524061 A5 JP 2023524061A5 JP 2022566315 A JP2022566315 A JP 2022566315A JP 2022566315 A JP2022566315 A JP 2022566315A JP 2023524061 A5 JP2023524061 A5 JP 2023524061A5
Authority
JP
Japan
Prior art keywords
seq
mutation
polypeptide
vector system
aav9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022566315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524061A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030298 external-priority patent/WO2021222831A2/en
Publication of JP2023524061A publication Critical patent/JP2023524061A/ja
Publication of JP2023524061A5 publication Critical patent/JP2023524061A5/ja
Withdrawn legal-status Critical Current

Links

JP2022566315A 2020-05-01 2021-04-30 操作された中枢神経系用組成物 Withdrawn JP2023524061A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063019221P 2020-05-01 2020-05-01
US63/019,221 2020-05-01
US202063061517P 2020-08-05 2020-08-05
US63/061,517 2020-08-05
PCT/US2021/030298 WO2021222831A2 (en) 2020-05-01 2021-04-30 Engineered central nervous system compositions

Publications (2)

Publication Number Publication Date
JP2023524061A JP2023524061A (ja) 2023-06-08
JP2023524061A5 true JP2023524061A5 (cg-RX-API-DMAC7.html) 2024-05-13

Family

ID=78373993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022566315A Withdrawn JP2023524061A (ja) 2020-05-01 2021-04-30 操作された中枢神経系用組成物

Country Status (7)

Country Link
US (1) US20230193316A1 (cg-RX-API-DMAC7.html)
EP (1) EP4143305A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023524061A (cg-RX-API-DMAC7.html)
CN (1) CN115867646A (cg-RX-API-DMAC7.html)
AU (1) AU2021264061A1 (cg-RX-API-DMAC7.html)
CA (1) CA3176506A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021222831A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166208B (zh) 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
US12630842B2 (en) 2020-05-13 2026-05-19 Voyager Therapeutics, Inc. Redirection of tropism of AAV capsids
CA3210955A1 (en) * 2021-02-09 2022-08-18 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
CA3216419A1 (en) * 2021-04-23 2022-10-27 Greg NACHTRAB Tissue-targeted modified aav capsids and methods of use thereof
WO2022226375A1 (en) * 2021-04-23 2022-10-27 Locanabio, Inc. Tissue-targeted modified aav capsids and methods of use thereof
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
EP4426716A1 (en) 2021-11-02 2024-09-11 Voyager Therapeutics, Inc. Aav capsid variants and uses thereof
WO2024046393A1 (zh) * 2022-08-30 2024-03-07 上海鲸奇生物科技有限公司 非神经元细胞转分化为神经元的方法及应用
AU2023364350A1 (en) 2022-10-19 2025-06-05 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
JP2026509271A (ja) 2023-03-10 2026-03-17 ダイノ セラピューティクス,インコーポレーテッド カプシドポリペプチドおよびその使用方法
AU2024271851A1 (en) 2023-05-16 2025-12-18 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
WO2025007046A1 (en) * 2023-06-29 2025-01-02 The Trustees Of The University Of Pennsylvania Mutant aav with central nervous system targeting motifs and compositions containing same
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
CN117165677A (zh) * 2023-11-03 2023-12-05 首都儿科研究所 检测生物标志物在制备神经管畸形疾病的产品的应用
WO2025160155A1 (en) 2024-01-22 2025-07-31 The Broad Institute, Inc. Epigenetic targeting of prion diseases
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160039877A1 (en) * 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
AU2015349759B2 (en) * 2014-11-21 2022-01-06 The University Of North Carolina At Chapel Hill Aav vectors targeted to the central nervous system
CA3172682A1 (en) * 2015-04-23 2016-10-27 Nantomics, Llc Cancer neoepitopes
AU2016366549B2 (en) * 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
AU2018350700B2 (en) * 2017-10-16 2025-04-24 VeonGen Therapeutics GmbH AAV vectors
IL278598B2 (en) * 2018-05-11 2025-11-01 Massachusetts Eye & Ear Infirmary Altering tissue tropism of adeno-associated viruses
EP3830107A2 (en) * 2018-08-03 2021-06-09 Voyager Therapeutics, Inc. Aav variants with enhanced tropism
CN113166208B (zh) * 2018-10-02 2024-11-22 沃雅戈治疗公司 重新定向aav衣壳的嗜性
WO2023039480A2 (en) * 2021-09-08 2023-03-16 The Broad Institute, Inc. Engineered central nervous system compositions

Similar Documents

Publication Publication Date Title
JP2023534999A5 (cg-RX-API-DMAC7.html)
EP1135468B1 (en) Virus vectors and methods of making and administering the same
JP2022551986A5 (cg-RX-API-DMAC7.html)
JP2024514956A5 (cg-RX-API-DMAC7.html)
JP2021512649A5 (cg-RX-API-DMAC7.html)
JP6174318B2 (ja) アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物
JP2022068181A5 (cg-RX-API-DMAC7.html)
JP2025500347A5 (cg-RX-API-DMAC7.html)
CN107864653B (zh) 衣壳
Brument et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and-5
JP2022529631A5 (cg-RX-API-DMAC7.html)
IL273261B2 (en) Adeno-associated virus variant capsids and methods of using them
JP2020511127A5 (cg-RX-API-DMAC7.html)
US20050106558A1 (en) Library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
JP2024530023A5 (cg-RX-API-DMAC7.html)
JP7541027B2 (ja) 筋肉発現のためのハイブリッドプロモーター
JP2007507223A5 (cg-RX-API-DMAC7.html)
JP2021523702A5 (cg-RX-API-DMAC7.html)
JP2023551873A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2021531044A5 (cg-RX-API-DMAC7.html)
JP2024515626A5 (cg-RX-API-DMAC7.html)
JP2021521782A5 (cg-RX-API-DMAC7.html)
JP2025516136A5 (cg-RX-API-DMAC7.html)
JP2025515356A5 (cg-RX-API-DMAC7.html)